Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

November 2, 2022

Primary Completion Date

February 14, 2025

Study Completion Date

February 14, 2025

Conditions
Irritability Associated With Autism Spectrum Disorder
Interventions
DRUG

Pimavanserin

Pimavanserin given once daily, as capsule of 10, 20, or 34 mg dose strength, respectively, according to the patient's age

Trial Locations (48)

3052

Murdoch Children's Research Institute, Parkville

3168

Monash Health, Clayton

4101

Children's Health Queensland Hospital and Health Service, South Brisbane

10314

ERG Clinical Research - New York, PLLC DBA Richmond Behavioral Associates, Staten Island

11000

Institute of Mental Health, Belgrade

18000

University Clinical Center Nis, Center for Mental Health, Niš

19146

The Children's Hospital of Philadelphia, Philadelphia

20010

Children's Research Institute, Washington D.C.

21000

Clinical Center of Vojvodina, Clinic for Psychiatry, Novi Sad

23842

La Nostra Famiglia - Scientifica IRCCS Eugenio Medea, Bosisio Parini

27100

Fondazione Istituto Neurologico Nazionale Casimiro Mondino - IRCCS, Pavia

29425

Medical University of South Carolina, Charleston

32607

The EHS Medical Practice, PA, D/B/A Sarkis Clinical Trials, Gainesville

33076

Centre Hospitalier Charles Perrens, Bordeaux

34000

University Clinical Center Kragujevac, Clinic for Psychiatry, Kragujevac

37126

Azienda Ospedaliera Universitaria Integrata di Verona (AOUI), Verona

44012

Quest Therapeutics of Avon Lake dba Haidar Almhana Nieding LLC, Avon Lake

44093

CHU de Nantes, Nantes

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

60563

AMR Baber Research Incorporated, Naperville

69678

Centre de Ressources Autisme Rhône-Alpes - Center Hospitalier le Vinatier, Bron

71122

Policlinico Riuniti - Azienda Ospedaliero Universitaria, Foggia

75019

L'Assistance Publique - Hôpitaux de Paris, labélisé Institut Carnot, Paris

75093

AIM Trials, LLC, Plano

75243

Relaro Medical Trials, LLC, Dallas

77090

Red Oak Psychiatry Associates, PA, Houston

80112

1st Allergy and Clinical Research Group, d/b/a IMUNOe Research Centers, Centennial

80131

"Azienda Ospedaliera Universitaria Federico II", Napoli

85006

Southwest Autism Research and Resource Center, Phoenix

89128

Clinical Research of Southern Nevada, LLC, Las Vegas

91361

Cortica Inc. (Glendale), Glendale

94903

Cortica Inc., San Rafael

98201

Eastside Therapeutic Resource, Inc. dba Core Clinical Research, Everett

32803-3809

APG Research, LLC, Orlando

H-1146

Magyarországi Református Egyház Bethesda Gyermekkórháza, Budapest

H-5700

Békés Megyei Központi Kórház, Gyula

H-6725

Szegedi Tudományegyetem, Szeged

00133

Fondazione PTV - Policlinico Tor Vergata, Rome

80-542

Gdańskie Centrum Zdrowia Sp. z o.o., Gdansk

80-546

Centrum Badań Klinicznych PI-House Sp. z o.o., Gdansk

91-129

NAVICULA - Centrum Diagnozy i Terapii Autyzmu, Lodz

50-414

Ginemedica Sp. Zoo, S. K., Wroclaw

54-238

Centrum Neuropsychiatrii Neuromed SP ZOZ, Wroclaw

54-617

MedicMental Indywidualna Specjalistyczna Praktyka Lekarska Monika Szewczuk-Boguslawska, Wroclaw

03010

Hospital General de Alicante, Alicante

08007

Institut Global d´Atenció Integral del Neurodesenvolupament (IGAIN), Barcelona

08035

Hospital Universitari Vall d'Hebron, Barcelona

08036

Hospital Clínic de Barcelona, Barcelona

Sponsors
All Listed Sponsors
lead

ACADIA Pharmaceuticals Inc.

INDUSTRY